Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, June 23, 2014

AbbVie raises 2014 adjusted profit forecast, (NYSE: ABBV)

U.S. drugmaker AbbVie Inc, which is trying to purchase London-listed peer Shire, raised its 2014 adjusted earnings forecast, citing strong "business performance" that it expects to continue for the rest of the year. The company now expects 2014 adjusted earnings of $3.06 to $3.16 per share, up from its prior view of $3.00 to $3.10.

AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. Shares of ABBV fell by 1.64% or $-0.89/share to $53.30. In the past year, the shares have traded as low as $41.07 and as high as $55.62. On average, 5803500 shares of ABBV exchange hands on a given day and today's volume is recorded at 13459409.